Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Mol Sci ; 20(15)2019 Jul 24.
Artículo en Inglés | MEDLINE | ID: mdl-31344879

RESUMEN

Rett syndrome (RTT) is a neurodevelopmental disorder, affecting 1 in 10,000 girls. Intellectual disability, loss of speech and hand skills with stereotypies, seizures and ataxia are recurrent features. Stringent diagnostic criteria distinguish classical Rett, caused by a MECP2 pathogenic variant in 95% of cases, from atypical girls, 40-73% carrying MECP2 variants, and rarely CDKL5 and FOXG1 alterations. A large fraction of atypical and RTT-like patients remain without genetic cause. Next Generation Sequencing (NGS) targeted to multigene panels/Whole Exome Sequencing (WES) in 137 girls suspected for RTT led to the identification of a de novo variant in STXBP1 gene in four atypical RTT and two RTT-like girls. De novo pathogenic variants-one in GABRB2 and, for first time, one in GABRG2-were disclosed in classic and atypical RTT patients. Interestingly, the GABRG2 variant occurred at low rate percentage in blood and buccal swabs, reinforcing the relevance of mosaicism in neurological disorders. We confirm the role of STXBP1 in atypical RTT/RTT-like patients if early psychomotor delay and epilepsy before 2 years of age are observed, indicating its inclusion in the RTT diagnostic panel. Lastly, we report pathogenic variants in Gamma-aminobutyric acid-A (GABAa) receptors as a cause of atypical/classic RTT phenotype, in accordance with the deregulation of GABAergic pathway observed in MECP2 defective in vitro and in vivo models.


Asunto(s)
Discapacidad Intelectual/genética , Proteína 2 de Unión a Metil-CpG/genética , Proteínas Munc18/genética , Síndrome de Rett/genética , Adolescente , Adulto , Niño , Femenino , Factores de Transcripción Forkhead/genética , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Discapacidad Intelectual/fisiopatología , Mutación , Proteínas del Tejido Nervioso/genética , Fenotipo , Proteínas Serina-Treonina Quinasas/genética , Receptores de GABA/genética , Receptores de GABA-A/genética , Síndrome de Rett/fisiopatología , Secuenciación del Exoma , Adulto Joven
2.
Hum Mutat ; 33(7): 1031-6, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22415763

RESUMEN

Rett syndrome (RTT) is a neurodevelopmental disorder with one principal phenotype and several distinct, atypical variants (Zappella, early seizure onset and congenital variants). Mutations in MECP2 are found in most cases of classic RTT but at least two additional genes, CDKL5 and FOXG1, can underlie some (usually variant) cases. There is only limited correlation between genotype and phenotype. The Rett Networked Database (http://www.rettdatabasenetwork.org/) has been established to share clinical and genetic information. Through an "adaptor" process of data harmonization, a set of 293 clinical items and 16 genetic items was generated; 62 clinical and 7 genetic items constitute the core dataset; 23 clinical items contain longitudinal information. The database contains information on 1838 patients from 11 countries (December 2011), with or without mutations in known genes. These numbers can expand indefinitely. Data are entered by a clinician in each center who supervises accuracy. This network was constructed to make available pooled international data for the study of RTT natural history and genotype-phenotype correlation and to indicate the proportion of patients with specific clinical features and mutations. We expect that the network will serve for the recruitment of patients into clinical trials and for developing quality measures to drive up standards of medical management.


Asunto(s)
Síndrome de Rett/genética , Bases de Datos Genéticas , Humanos , Proteína 2 de Unión a Metil-CpG/genética , Mutación
3.
Neuropediatrics ; 43(1): 37-43, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22430159

RESUMEN

UNLABELLED: Rett syndrome (RTT) is a severe neurodevelopmental disorder affecting almost exclusively females. The Hanefeld variant, or early-onset seizure variant, has been associated with mutations in CDKL5 gene. AIMS: In recent years more than 60 patients with mutations in the CDKL5 gene have been described in the literature, but the cardiorespiratory phenotype has not been reported. Our aim is to describe clinical and autonomic features of these girls. METHODS: 10 girls with CDKL5 mutations and a diagnosis of Hanefeld variant have been evaluated on axiological and clinical aspects. In all subjects an evaluation of the autonomic system was performed using the Neuroscope. RESULTS: Common features were gaze avoidance, repetitive head movements and hand stereotypies. The autonomic evaluation disclosed eight cases with the Forceful breather cardiorespiratory phenotype and two cases with the Apneustic breather phenotype. CONCLUSIONS: The clinical picture remains within the RTT spectrum but some symptoms are more pronounced in addition to the very early onset of seizures. The cardiorespiratory phenotype was dominated by Forceful breathers, while Feeble breathers were not found, differently from the general Rett population, suggesting a specific behavioral and cardiorespiratory phenotype of the RTT the Hanefeld variant.


Asunto(s)
Enfermedades del Sistema Nervioso Autónomo/etiología , Mutación/genética , Proteínas Serina-Treonina Quinasas/genética , Síndrome de Rett/complicaciones , Síndrome de Rett/genética , Adolescente , Enfermedades del Sistema Nervioso Autónomo/genética , Encéfalo/patología , Niño , Preescolar , Evaluación de la Discapacidad , Electroencefalografía , Epilepsia/etiología , Femenino , Humanos , Imagen por Resonancia Magnética , Proteína 2 de Unión a Metil-CpG/genética , Fenotipo , Síndrome de Rett/diagnóstico , Índice de Severidad de la Enfermedad
4.
Epilepsy Behav ; 19(3): 296-300, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20728410

RESUMEN

Epilepsy often occurs in Rett syndrome and is considered a major problem. The aim of this study was to define the clinical features of epilepsy and the correlation between seizures and both genotype and clinical phenotype in the Rett population. One hundred sixty-five patients with Rett syndrome referred to four Italian centers were recruited. All patients underwent video/EEG monitoring and molecular analysis of the MECP2 gene or, in negative cases, of the CDKL5 and FOXG1 genes. The frequency of epilepsy was 79%. Drug-resistant epilepsy occurred in 30% of all our patients with Rett syndrome and in 38% of those with epilepsy. Our findings demonstrate that epilepsy differs among the various phenotypes and genotypes with respect to age at onset, drug responsiveness, and seizure semiology. The Hanefeld and preserved speech variants represent the extremes of the range of severity of epilepsy: the preserved speech variant is characterized by the mildest epileptic phenotype as epilepsy is much less frequent, starts later, and is less drug resistant than what is observed in the other phenotypes. Another important finding is that seizure onset before 1 year of age and daily frequency are risk factors for drug resistance. Thus, this study should help clinicians provide better clinical counseling to the families of patients with Rett syndrome.


Asunto(s)
Epilepsia/genética , Proteína 2 de Unión a Metil-CpG/genética , Proteínas Serina-Treonina Quinasas/genética , Síndrome de Rett/genética , Adulto , Edad de Inicio , Distribución de Chi-Cuadrado , Niño , Preescolar , Electroencefalografía , Epilepsia/etiología , Femenino , Genotipo , Humanos , Masculino , Mutación/genética , Fenotipo , Estudios Retrospectivos , Síndrome de Rett/complicaciones , Adulto Joven
5.
Int J Genomics ; 2019: 6956934, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31049350

RESUMEN

Rett spectrum disorder is a progressive neurological disease and the most common genetic cause of intellectual disability in females. MECP2 is the major causative gene. In addition, CDKL5 and FOXG1 mutations have been reported in Rett patients, especially with the atypical presentation. Each gene and different mutations within each gene contribute to variability in clinical presentation, and several groups worldwide performed genotype-phenotype correlation studies using cohorts of patients with classic and atypical forms of Rett spectrum disorder. The Rett Networked Database is a unified registry of clinical and molecular data of Rett patients, and it is currently one of the largest Rett registries worldwide with several hundred records provided by Rett expert clinicians from 13 countries. Collected data revealed that the majority of MECP2-mutated patients present with the classic form, the majority of CDKL5-mutated patients with the early-onset seizure variant, and the majority of FOXG1-mutated patients with the congenital form. A computation of severity scores further revealed significant differences between groups of patients and correlation with mutation types. The highly detailed phenotypic information contained in the Rett Networked Database allows the grouping of patients presenting specific clinical and genetic characteristics for studies by the Rett community and beyond. These data will also serve for the development of clinical trials involving homogeneous groups of patients.

6.
Epilepsy Res ; 77(1): 44-61, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17875384

RESUMEN

PURPOSE: To describe resistant epileptic encephalopathies that significantly improved after an acute febrile episode (FE). METHODS: We reviewed the clinical history of patients with daily pharmacoresistant seizures referred to the Saint-Vincent de Paul Hospital in the last 5 years. Four patients experienced seizure arrest in relation with a febrile episode. RESULTS: The four patients suffered from epileptic encephalopathy. Three were symptomatic, one cryptogenic. They presented spasms and atypical absences, beginning after the age of 1 year. All seizures stopped at the onset of fever, and significant EEG improvement was observed. The seizure-free period ranged from 2 to 24 months. DISCUSSION AND CONCLUSION: The close link between the occurrence of FE and the disappearance of seizures and EEG improvement, contrasting with the previous pharmacoresistance of this epileptic encephalopathy, supports a non fortuitous association. Several mechanisms could explain this phenomenon, including viral etiology, hyperthermia, inflammatory-immune reaction and ACTH release. Better understanding this phenomenon could open new therapeutic perspectives.


Asunto(s)
Encefalopatías/terapia , Epilepsia/terapia , Hipertermia Inducida , Hormona Adrenocorticotrópica/metabolismo , Adulto , Anticonvulsivantes/uso terapéutico , Encefalopatías/complicaciones , Encefalopatías/virología , Resistencia a Medicamentos , Electroencefalografía , Encefalitis por Herpes Simple/patología , Encefalitis por Herpes Simple/virología , Epilepsia/etiología , Epilepsia/virología , Femenino , Lateralidad Funcional , Humanos , Inflamación/patología , Imagen por Resonancia Magnética , Masculino , Estudios Retrospectivos , Espasmo/etiología , Lóbulo Temporal/patología
7.
J Child Neurol ; 22(6): 769-72, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17641268

RESUMEN

Hyperekplexia (OMIM 149400) is an uncommon neurologic disorder characterized by exaggerated response to sensitive stimuli. It may be sporadic or familial. The disease is usually caused by mutations in the inhibitory glycine receptor alpha1-subunit. The authors report a male patient who is affected by the major form of familial hyperekplexia. He is currently 5 years old and is being successfully treated with clonazepam. Prenatal diagnosis was made owing to prior identification of point mutation K276E in his affected mother. Early diagnosis avoided complex and prolonged differential diagnostic procedures and allowed for early and effective intervention on severe neonatal symptoms: hypertonia, episodes of cyanosis, apneic spells, and massive myoclonic jerks. During his first year of life, the patient was treated with cycles of phenobarbital and diazepam and achieved partial clinical response. Subsequent therapy with low-dose clonazepam was highly effective in reducing myoclonic jerks and exaggerated startle reaction, and unlike previously used drugs, it was decisive in reducing hypertonia.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Clonazepam/uso terapéutico , Salud de la Familia , Hipertonía Muscular , Diagnóstico Prenatal , Reflejo Anormal , Preescolar , Femenino , Ácido Glutámico/genética , Humanos , Lisina/genética , Masculino , Hipertonía Muscular/diagnóstico , Hipertonía Muscular/tratamiento farmacológico , Hipertonía Muscular/genética , Mutación Puntual , Embarazo , Receptores de Glicina/genética
8.
World J Biol Psychiatry ; 17(3): 198-209, 2016 04.
Artículo en Inglés | MEDLINE | ID: mdl-26469135

RESUMEN

OBJECTIVES: Oxidative stress seems to be involved in Rett syndrome (RTT). The aim of this study was to assess the antioxidant status in RTT children with MECP2 gene mutations with respect to healthy controls, and to explore novel blood antioxidant markers for RTT severity. METHODS: In erythrocytes from RTT females aged 2-14 years (n = 27) and age-matched controls (n = 27), we measured the levels of malonaldehyde and the activity of two antioxidant enzymes, Cu/Zn-superoxide dismutase and catalase, by spectrophotometric assays. In leukocytes, the expression of metallothioneins, the main non-enzymatic antioxidants, was assessed by real-time RT-PCR. In nine selected RTT children, methylome analysis was also performed. RESULTS: Blood of RTT patients showed increased lipid peroxidation and a dysregulated pattern of MT expression, while enzymatic activities did not change significantly with respect to controls. Moreover, we observed no epigenetic dysregulation in CpG-enriched promoter regions of the analysed genes but significant hypomethylation in the random loci. CONCLUSIONS: As the haematic level of MT-1A directly correlates with the phenotype severity, this metallothionein can represent a marker for RTT severity. Moreover, the attempt to link the level of blood oxidative stress with MECP2 mutation and specific clinical features led us to draw some interesting conclusions.


Asunto(s)
Metilación de ADN , Metalotioneína/metabolismo , Proteína 2 de Unión a Metil-CpG/genética , Estrés Oxidativo , Síndrome de Rett/genética , Adolescente , Biomarcadores , Estudios de Casos y Controles , Niño , Preescolar , Análisis Mutacional de ADN , Femenino , Humanos , Metalotioneína/genética , Mutación , Análisis de Regresión
9.
Eur J Paediatr Neurol ; 19(4): 446-52, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25814391

RESUMEN

PURPOSE: We investigated drugs most often used to treat epilepsy in Rett Syndrome and their efficacy in a large cohort of Italian patients. METHODS: This is a multi-centre retrospective study. Data of 165 Rett subjects were collected from the patients' files, and hospital charts. The efficacy of antiepileptic drugs (AEDs) was classified as follows: not effective; decrease in seizure frequency ≥50% for at least 6 months; seizure-free for at least 2 years. Phenotypic and genetic categorization of patients was performed and it was considered in AEDs efficacy evaluation. RESULTS: There were 130 epileptic patients.Sodium valproate (VPA) was the most commonly administered AED (44.3%) at seizure onset, followed by Carbamazepine (CBZ) (25.4%) and Phenobarbital (PB) (13%). Monotherapy was the first treatment option in most patients. VPA and CBZ proved to be equally effective in Rett patients who presented seizures within the typical age range (4-5 years), while Lamotrigine (LTG) was effective for patients in whom epilepsy started later. Overall, the frequency of side effects was low and the most often observed ones were restlessness and somnolence. CONCLUSION: Our study suggests that LTG, VPA and CBZ can be used as drugs of first choice in Rett Syndrome. The association of four drugs should be avoided since it did not result in any significant clinical improvement.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Epilepsia/tratamiento farmacológico , Síndrome de Rett/tratamiento farmacológico , Adolescente , Adulto , Anciano , Carbamazepina/uso terapéutico , Epilepsia/etiología , Femenino , Humanos , Lamotrigina , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Síndrome de Rett/complicaciones , Resultado del Tratamiento , Triazinas/uso terapéutico , Ácido Valproico/uso terapéutico
10.
Ital J Pediatr ; 35(1): 23, 2009 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-19646249

RESUMEN

Recent studies suggested a link between type 1 diabetes mellitus and pervasive developmental disorder. Moreover, permanent neonatal diabetes mellitus due to pancreatic agenesis can be associated with neurological deficit involving cerebellar functions, but no association with pervasive developmental disorder has been described so far. Clinical and neuropsychological evaluation of a child with pancreatic agenesis, mental retardation and pervasive developmental disorder is reported.

11.
Epilepsy Behav ; 12(2): 326-31, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18063413

RESUMEN

Clinical features and electroencephalographic findings of two patients affected by a previously unreported cyclin-dependent kinase-like 5 (CDKL5) gene mutation are described. Both patients had the Hanefeld variant phenotype with early-onset seizures, but different degrees of clinical severity. In fact, patient 1 was not drug-resistant and is responding to a single drug. On the contrary, patient 2, like most reported cases, has severe epilepsy, exhibits electroencephalographic changes, and is drug resistant. We suggest that the pseudoperiodic patterns observed on the EEGs for these cases represent this genetic form of epilepsy, though differing in frequency, voltage, and associated patterns. This is in agreement with data reported by other authors indicating that no unique pattern can be identified in subjects with CDKL5 mutations. Thus, a CDKL5 investigation should be performed in developmentally delayed patients with early-onset seizures, including drug-resistant subjects with severe EEG changes, as well as in patients with milder, drug-responsive forms of epilepsy.


Asunto(s)
Discapacidades del Desarrollo/genética , Epilepsia/genética , Mutación/genética , Proteínas Serina-Treonina Quinasas/genética , Síndrome de Rett/genética , Niño , Discapacidades del Desarrollo/complicaciones , Discapacidades del Desarrollo/fisiopatología , Electroencefalografía , Epilepsia/etiología , Epilepsia/fisiopatología , Femenino , Humanos , Síndrome de Rett/complicaciones , Síndrome de Rett/fisiopatología , Índice de Severidad de la Enfermedad
12.
Am J Med Genet A ; 140(18): 1944-9, 2006 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-16906558

RESUMEN

Mental retardation, facial dysmorphisms, seizures, and brain abnormalities are features of 6q terminal deletions. We have ascertained five patients with 6q subtelomere deletions (four de novo, one as a result of an unbalanced translocation) and determined the size of the deletion ranging from 3 to 13 Mb. Our patients showed a recognizable phenotype including mental retardation, characteristic facial appearance, and a distinctive clinico-neuroradiological picture. Focal epilepsy with consistent electroencephalographic features and with certain brain anomalies on neuroimaging studies should suggest 6q terminal deletion. The awareness of the distinctive clinical picture will help in the diagnosis of this chromosomal abnormality.


Asunto(s)
Encéfalo/anomalías , Aberraciones Cromosómicas , Cromosomas Humanos Par 6/genética , Epilepsias Parciales/diagnóstico , Facies , Discapacidad Intelectual/diagnóstico , Adulto , Deleción Cromosómica , Electroencefalografía , Epilepsias Parciales/genética , Femenino , Humanos , Lactante , Discapacidad Intelectual/genética , Masculino , Fenotipo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA